 |
The STAR Trial
We're looking for 22,000 women who are at increased risk for developing breast cancer.
The STAR Trial is comparing the effectiveness of two drugs, tamoxifen and raloxifene, in reducing the occurrence of breast cancer in postmenopausal women age 35 or older who are at increased risk for developing breast cancer.
Participants will be assigned by chance to receive one of the drugs. Neither the women nor their doctors will know which drug they will be taking. Trained health professionals will closely monitor all participants through regularly scheduled health examinations during the trial.
Your risk depends on a combination of lifestyle and personal traits known as "risk factors". These can include: a family history of breast cancer, your age, never having borne a child, having your first child after age 30, first menstrual period at an early age, a history of breast biopsies, or other breast conditions.
For more information on this important study, please contact:
Beverly Brunker, RN, BSN
STAR Study Coordinator
(330) 884-4176
xxx Mammography xxx Forum Health At Home Hospice xxx Our Physicians xxx Clinical Trials and Research xxx Genetics xxx Support & Education xxx Cancer Prevention & Control xxx Cancer Registry xxx xx Community Outreach xxx Professional Education xxxx Current Events Spotlight xxxx Newsletters & Calendars